7Caldwell SH, Hespenheide EE. Subacute liver failure in obese women. Am J Gastroenterol,2002,97:2058-2062.
8Bugianesi E, Lenoe N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology, 2002,123 : 134-140.
2[1]Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 2002, 123:1705～ 1725.
3[2]Day CP, James OF. Steatohepatitis: a tale of two "hits"?Gastroenterology, 1998, 114: 842～845.
4[3]Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol, 2003, 18: 124～138.
5[4]Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 2003, 37:1202～1219.
6[5]Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol, 2002, 33:1098 ～ 1104.
7[6]Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.Hepatology, 2002, 36: 1349～1354.
8[7]Sorensen HT, Mellemkjaer L, Jepsen P, Thulstrup AM, Baron J, Olsen JH, Vilstrup H. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. J Clin Gastroenterol, 2003,36: 356～359.
9[8]Marchesini G, Bugianesi E, Forlani G, Cerrelli F,Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003, 37: 917～923.
10[9]American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1702～1704.
